Clinical Trial Update: BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories [Phase 1]

View source ↗

Summary

This entry describes an early-phase Phase 1 clinical trial (BONSAI) exploring biomarkers related to nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer's Disease | Phase 1 | Status: UNKNOWN